David Perdue (R-GA), a U.S. Senator, has disclosed 50 trades in Merck & Company Inc (MRK) since 2017, 28 purchases and 22 sales, worth an estimated $1.6M in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: David Perdue sold $1,001 - $15,000 of Merck & Company Inc (NYSE: MRK) on April 16, 2020. Since that trade, MRK is up +74.98% against the S&P 500 up +193.99%, an outperformance of -119.01%.
Across these filings, David Perdue has been a net buyer of MRK (a buy-to-sell ratio of 1.27). Each row in the table below links to that trade and its post-trade performance versus the market.
MRK trades
50
Disclosed Vol
$1.6M
Buys
28
56%
Sells
22
44%
Buy / Sell
1.27
ratio
First → Last
2017–2020
David Perdue's MRK trades vs the price
MRK is up +74.98% since David Perdue sold on April 16, 2020, versus +193.99% for the S&P 500.
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.
